Roughly 20 to 40% of people infected with SARS-CoV-2 never develop symptoms at all. That range has shifted over the course of the pandemic depending on the variant, the age of the person infected, and vaccination status, but the consistent finding is that a substantial share of infections are completely silent. Understanding how common these cases are matters because it shapes how the virus spreads and whether testing catches it.
What “Asymptomatic” Actually Means
There’s an important distinction between truly asymptomatic infections and presymptomatic ones. A truly asymptomatic person tests positive but never develops any symptoms throughout the entire course of infection. A presymptomatic person feels fine at the time of testing but goes on to get sick days later.
Early research in a skilled nursing facility, published in the New England Journal of Medicine, showed just how tricky this distinction is. Of 48 residents who tested positive, 56% had no symptoms at the time of testing. But when researchers followed up seven days later, 24 of those 27 asymptomatic residents had developed symptoms, with a median onset of four days. That means only 3 of the 27 were truly asymptomatic. Studies that don’t follow up long enough can dramatically overcount asymptomatic cases by lumping in people who simply haven’t gotten sick yet.
How Rates Differ by Age
Children and teenagers are the most likely to have silent infections. A global meta-analysis published in The Pediatric Infectious Disease Journal found that the asymptomatic proportion peaks at about 36% around age 13 to 14, then gradually declines through adulthood. By age 40 to 50, the rate levels off at a lower plateau, and by age 90 it drops to roughly 8%. In practical terms, an infected teenager is more than four times as likely to stay symptom-free as an infected person in their 90s.
This pattern held for the Omicron era as well. A CDC-published study of children in China found that about 60% of pediatric SARS-CoV-2 infections were asymptomatic. Among children aged 7 to 15 specifically, about 54% had no symptoms, a figure consistent with U.S. seroprevalence data showing roughly half of Omicron infections in kids aged 5 to 15 were symptomatic. Delta infections, by comparison, produced symptoms more often in the same age groups.
Omicron Changed the Numbers
The Omicron variant and its subvariants generally produced milder illness than earlier strains, which shifted the asymptomatic ratio. Meta-analyses found that the asymptomatic proportion associated with Omicron varied widely, from 14% to 57% across studies and age groups. That broad range reflects differences in how studies defined “asymptomatic,” how long they followed participants, and which populations they sampled. Still, the overall trend was clear: Omicron was more likely to cause silent infections than Delta was.
Vaccination Shifts the Balance
Vaccination makes it more likely that a breakthrough infection will be mild or asymptomatic, though it doesn’t eliminate the possibility of illness. Early CDC data from the first four months of 2021 found that among reported vaccine breakthrough infections, about 27% were completely asymptomatic. The remaining cases included people with symptoms of varying severity. These numbers came from a period when the original strain and Alpha variant dominated, before Omicron made breakthrough infections far more common but generally milder.
Asymptomatic Spread Is Real but Limited
One of the biggest concerns about silent infections is whether people without symptoms can spread the virus. They can, but far less efficiently than someone who is coughing and sneezing. A large meta-analysis in JAMA Network Open found that the household secondary attack rate from symptomatic cases was 18%, meaning roughly one in five household contacts got infected. From asymptomatic cases, that rate dropped to just 0.7%. That’s a striking difference: symptomatic people were roughly 25 times more likely to infect someone in their household.
This doesn’t mean asymptomatic transmission is negligible at a population level. Because asymptomatic people don’t know they’re infected, they continue normal activities and contact patterns, potentially exposing far more people over a longer period than someone who feels sick and stays home.
Rapid Tests Often Miss Silent Infections
If you’ve ever wondered whether a negative rapid test means you’re truly in the clear, the answer depends heavily on whether you have symptoms. CDC data from university testing in Wisconsin found that rapid antigen tests had 80% sensitivity in symptomatic people but only 41% sensitivity in asymptomatic people. That means the test missed nearly 6 out of 10 asymptomatic infections that PCR testing confirmed. Specificity remained high in both groups (around 98 to 99%), so a positive rapid test was still reliable. But a negative result in someone without symptoms was far less reassuring.
This gap exists because asymptomatic people tend to carry lower viral loads, producing less of the protein that antigen tests detect. If you’re testing after a known exposure but feel fine, a single negative rapid test is not particularly reliable. Serial testing over several days improves the odds of catching an infection.
Long COVID After Silent Infections
Having no symptoms during the initial infection doesn’t guarantee you’ll avoid lingering problems. A review published in Pathogens found that post-COVID syndrome developed in 30 to 60% of patients who had asymptomatic or mild infections. The most common persistent symptoms were fatigue, shortness of breath, cough, and loss of smell. Women were disproportionately affected.
That range is wide and comes from studies with varying follow-up periods and definitions of post-COVID syndrome. But the core finding is consistent: even people who felt nothing during their acute infection can experience weeks or months of symptoms afterward. This is one reason public health experts have emphasized that “mild” or “asymptomatic” infection is not the same as “harmless” infection.